BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19220901)

  • 1. Accidental Jorge Lobo's disease in a worker dealing with Lacazia loboi infected mice: a case report.
    Rosa PS; Soares CT; Belone Ade F; Vilela R; Ura S; Filho MC; Mendoza L
    J Med Case Rep; 2009 Feb; 3():67. PubMed ID: 19220901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jorge Lobo's disease.
    Carvalho KA; Floriano MC; Enokihara MM; Mascarenhas MR
    An Bras Dermatol; 2015; 90(4):586-8. PubMed ID: 26375233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jorge Lobo's disease: a case of keloidal blastomycosis (lobomycosis) in a nonendemic area.
    Arju R; Kothadia JP; Kaminski M; Abraham S; Giashuddin S
    Ther Adv Infect Dis; 2014 Jun; 2(3-4):91-6. PubMed ID: 25469235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive squamous-cell carcinoma in Jorge Lobo's disease: Report of two cases and review of the literature.
    de Brito AC
    Med Mycol Case Rep; 2022 Sep; 37():13-16. PubMed ID: 35712462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Lobo's disease.
    Quaresma JA; Unger D; Pagliari C; Sotto MN; Duarte MI; de Brito AC
    Acta Trop; 2010 Apr; 114(1):59-62. PubMed ID: 20044969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jorge Lobo's disease with malignant degeneration to squamous cell carcinoma: case report.
    de Brito AC; Bittencourt MJS; Gonçalves TDS; Cavalcante RH
    An Bras Dermatol; 2022; 97(1):93-95. PubMed ID: 34836741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the association between human leukocyte antigens and Jorge Lobo's disease].
    Marcos EV; Souza FC; Torres EA; Lauris JR; Opromolla DV
    Rev Soc Bras Med Trop; 2005; 38(5):399-401. PubMed ID: 16172755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage in BALB/c mice infected with Lacazia loboi and its relation to nutritional status.
    Barbosa AS; de Oliveira LR; Tavares FC; de Lima CR; Diório SM; Calvi SA; Vilani-Moreno FR; Pereira PC
    J Venom Anim Toxins Incl Trop Dis; 2015; 21():10. PubMed ID: 25821459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobomycosis: A case from Southeastern Europe and review of the literature.
    Papadavid E; Dalamaga M; Kapniari I; Pantelidaki E; Papageorgiou S; Pappa V; Tsirigotis P; Dervenoulas I; Stavrianeas N; Rigopoulos D
    J Dermatol Case Rep; 2012 Sep; 6(3):65-9. PubMed ID: 23091581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacaziosis - unusual clinical presentation.
    Sousa PP; Schettini AP; Rodrigues CA; Westphal DC
    An Bras Dermatol; 2015; 90(2):268-9. PubMed ID: 25831004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional status and immune response in murine experimental Jorge Lobo's disease.
    Barbosa AS; Diório SM; Pedrini SC; Silva SM; Sartori BG; Calvi SA; Pereira PC; Vilani-Moreno FR
    Mycoses; 2015 Sep; 58(9):522-30. PubMed ID: 26156007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxic T cells may contribute to the in situ immune response in Jorge Lobo's Disease human lesions.
    Alexandre AF; Quaresma JA; Barboza TC; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Kanashiro-Galo L; Sotto MN; Duarte MI; Pagliari C
    Med Mycol; 2017 Feb; 55(2):145-149. PubMed ID: 27562863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of microvasculature phenotype and endothelial activation markers in skin lesions of lacaziosis (Lobomycosis).
    Quaresma JA; Brito MV; Sousa JR; Silva LM; Hirai KE; Araujo RS; de Brito AC; Carneiro FR; Fuzii HT; Pagliari C; Sotto MN; Duarte MI
    Microb Pathog; 2015 Jan; 78():29-36. PubMed ID: 25450888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage and TGF-beta immunohistochemical expression in Jorge Lobo's disease.
    Xavier MB; Libonati RM; Unger D; Oliveira C; Corbett CE; de Brito AC; Quaresma JA
    Hum Pathol; 2008 Feb; 39(2):269-74. PubMed ID: 17959227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular study of archival fungal strains isolated from cases of lacaziosis (Jorge Lobo's disease).
    Vilela R; Martins JE; Pereira CN; Melo N; Mendoza L
    Mycoses; 2007 Nov; 50(6):470-4. PubMed ID: 17944708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jorge Lobo's disease with restricted labial presentation.
    Miranda MF; Unger DA; Brito AC; Carneiro FA
    An Bras Dermatol; 2011; 86(2):373-4. PubMed ID: 21603828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the phagocytic activity of peripheral blood monocytes of patients with Jorge Lobo's disease.
    Vilani-Moreno FR; Silva LM; Opromolla DV
    Rev Soc Bras Med Trop; 2004; 37(2):165-8. PubMed ID: 15094903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and prompt treatment by surgery in Jorge Lobo's disease (keloidal blastomycosis).
    Baruzzi RG; Marcopito LF; Michalany NS; Livianu J; Pinto NR
    Mycopathologia; 1981 Apr; 74(1):51-4. PubMed ID: 7242649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic isolation of Lacazia loboi cells from skin lesions of lobomycosis.
    Salgado CG; Tavares LS; Plautz HL; Da Silva MB; Yamano SS; Da Costa PF; Hamoy IG; Marinho AN; Santos AK; Salgado UI; Da Silva JP
    Med Mycol; 2009 Mar; 47(2):119-23. PubMed ID: 18651310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental reproduction of the Jorge Lobo's disease in BAlb/c mice inoculated with Lacazia loboi obtained from a previously infected mouse.
    Belone AF; Madeira S; Rosa PS; Opromolla DV
    Mycopathologia; 2002; 155(4):191-4. PubMed ID: 12650594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.